Q4H-15343-34987 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-07-13
Registered in v-safe
2021-07-13
Dose 1 — Janssen/Johnson & Johnson
2021-07-13
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-07-15
Survey response — days 1–6 daily, dose 1
MedDRA: Vision blurred — Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Blurry visio

MedDRA releases: 2021-09,2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-07-13	Janssen/Johnson & Johnson	No

Free text

Release 9 — days 1–6 daily, dose 1

2021-07-15

Systemic reaction (other): Blurry visio

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Vision blurred	✓	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release